期刊文献+

术中放疗辅助下早期乳腺癌保乳根治术的临床分析 被引量:12

Clinical analysis of intraoperative radiotherapy-assisted breast conserving surgery for early-stage breast cancer
原文传递
导出
摘要 目的:初步探讨INTRABEAM术中放疗(IORT)辅助下早期乳腺癌保乳根治术的可行性和安全性。方法:选择2012年11月—2013年7月期间符合入组条件的17例女性早期乳腺癌患者,患者均行IORT辅助下保乳根治术。观察患者术后手术部位的情况,局部并发症以及急性放射损伤的发生率;通过门诊随访方式评判乳房美容效果并分析近期疗效。结果:所有患者均完成IORT辅助下保乳根治术,术中照射的中位数时间为25(20~35)min。4例患者(23.5%)术后需接受全乳房外照射。术后的早期并发症主要包括残腔积液较多(11.8%),较明显的皮肤红肿(17.6%)。无明显残腔血肿或者伤口感染病例,患者对术中放疗的耐受性良好。早期随访显示,患侧乳房术后的美容效果优良率76.5%,无复发生存率、无转移生存率、总生存率均为100%。结论:IORT辅助下保乳根治术用于特定的早期乳腺癌患者是相对安全可行的。 Objective: To investigate the feasibility and safety of breast conserving surgery for early-stage breast cancer with the assistance of INTA BEAM intraoperative radiotherapy(IORT).Methods: Seventeen eligible female patients with early-stage breast cancer were enrolled from November 2012 to July 2013, and all of them underwent IORT-assisted radical breast conserving surgery. The surgical site condition, incidence of local complications and acute radiation injury in the patients were observed after surgery, and the cosmetic results of the breast and short-term therapeutic efficacy were assessed through follow-up clinical visits.Results: IORT-assisted radical breast conserving surgery was completed in all patients with a median intraoperative irradiation time of 25(20–35) min. Four patients(23.5%) needed external whole-breast irradiation after operation. The main early postoperative complications included excessive fluid in the residual dead space(11.8%), and evident redness and swelling of the skin of the breast(17.6%). No evident hematoma in the residual dead space or wound infection was noted in any of the patients, and all patients tolerated the intraoperative irradiation well. The early follow-up survey showed that the good cosmetic rate of the affected breast after surgery was 76.5%, and there was 100% rate of relapse-free survival, metastasisfree survival and overall survival. Conclusion: IORT-assisted radical breast conserving surgery is relatively safe and reliable for selected patients with early-stage breast cancer.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2014年第11期1467-1471,共5页 China Journal of General Surgery
关键词 乳腺肿瘤 乳房切除术 近距离放射疗法 Breast Neoplasms Mastectomy Brachytherapy
  • 相关文献

参考文献19

  • 1Clarke M, Collins R, Darhy S, et al. Effects of radiotherapy and of differences in the exlent of surgery for early breast cancer on local reeurrence and 15-year survival: an overview of the randomized trial[J]. Lancet, 2005, 366(9503):2087-2106.
  • 2Reintgen C, Reintgen D, Solin LJ. Advances in local-regional treatment for patients with early-stage breast cancer: a review of the field[J]. Clin Breast Cancer, 2010, 10(3):180-187.
  • 3Lucy Mansfield,Avi Agrawal,Ramsey I. Cutress.乳腺癌保乳整复手术[J].中国普通外科杂志,2013,22(11):1379-1382. 被引量:4
  • 4胡小波,唐利立.新辅助化疗后隐匿性乳腺癌放射定位保乳术疗效观察[J].中国普通外科杂志,2013,22(5):652-655. 被引量:13
  • 5Vaidya JS, Tobias JS, Baum M, et at. Intraoperative radiotherapy for breast cancer[J]. Lancet Oncol, 2004, 5(3): 165-173.
  • 6Vaidya JS, Joseph DJ, Tobias JS, el al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non- inferiority phase 3 trial[J]. Lancet, 2010, 376(9735):91-102.
  • 7Osti MF, Carnevale A, Bracci S, et al. Exclusive electron intraoperative radiotherapy in early-stage breast cancer: a monoinstitulional experience[J]. Anticancer Res, 2013, 33(3):1229- 1235.
  • 8Stmad V, Hildebrandt G, Petter R, et al. Accelerated partial breast irradiation: 5-year results of the German-Austrian multieenter phase II trial using interstitial multieatheter braehytherapy alone after breast-conserving surgery[J].lnt J Radiat Oncol Biol Phys, 2011, 80(1):17-24.
  • 9Belkacdmi Y, Chauvet MP, Giard S, et al. Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase 11 study[J]. Radiother Oneol, 2009, 90(1):23-29.
  • 10Chen PY, Wallace M, Mitchell C, et ah Four-year efficacy, cosmesis, and toxicity using three-dimensional eonformal external beam radiation therapy to deliver accelerated partial breast irradiation[J]. Int J Radiat Oneol Biol Phys, 2010, 76(4):991-997.

二级参考文献32

  • 1Beriwal S, Schwartz GF, Komarnicky L, et al. Breast-conserving therapy after neoadjuvant chemotherapy: long-term resuhs[J]. Breast J, 2006. 12(2):159-164.
  • 2van der Ploeg IM, Hobbelink M, van den Bosch MA, et al. 'Radioguided occuh lesion localisation' (ROI.L) for non-palpable breast lesions: a review of the relevant literature[J]. Eur J Surg Oncol, 2008, 34(1):1-5.
  • 3van Riet YE. Maaskant AJ, Creemers GJ, et al. Identification of residual breast lunlo/ir loealizalion afiler neo-adjuvanl chemotherapy using a radioactive 125 Iodine seed[J]. Eur J Surg Oneol, 2010, 36(2): 164-169.
  • 4Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials[J]. Lancet, 2005, 366(9503):2087-2106.
  • 5Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer[J]. N Engl J Med, 2002, 347(16):1233-1241.
  • 6Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer[J]. N Engl J Med, 2002, 347(16):1227-1232.
  • 7Schwartz GF, Veronesi U, Clough KB, et al. Proceedings of the consensus conference on breast conservation, April 28 to May 1, 2005, Milan, Italy[J]. Cancer, 2006, 107(2):242-250.
  • 8Berrino P, Campora E, Santi P. Postquadrantectomy breast deformities: classification and techniques of surgical correction[J]. Plast Reconstr Surg, 1987, 79(4):567-572.
  • 9Gabka C J, Maiwald G, Baumeister RG. Expanding the indications spectrum for breast saving therapy of breast carcinoma by oncoplastic operations[J]. Langenbecks Arch Chir Suppl Kongressbd, 1997, 114:1224-1227.
  • 10Audretsch WP. Reconstruction of the partial mastectomy defect: classification and method. Surgery of the breast: principles and art[M]. Philadelphia: Lippincott Raven, 1998.

共引文献15

同被引文献90

  • 1须捷平,徐曙光,张云,俞羚,吴连明,殷志强,曹晖.三阴性乳腺癌的临床病理特征和预后影响因素分析[J].上海交通大学学报(医学版),2011,31(5):637-641. 被引量:18
  • 2George Plataniotis.Hypofractionated radiotherapy in the treatment of early breast cancer[J].World Journal of Radiology,2010,2(6):197-202. 被引量:5
  • 3Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014[J]_ CA Cancer JClin, 2014, 64(1):9-29.
  • 4Gonzalez-Angulo AM, Litton JK, Broglio KR, et al. High riskof recurrence for patients with breast cancer who have humanepidermal growth factor receptor 2-positive, node-negative tumors1 cm or smaller[J], J Clin Oncol, 2009, 27(34):5700-5706.
  • 5Le Du F, Eckhardt BL, Lim B, et al. Is the future of personalizedtherapy in triple-negative breast cancer based on molecularsubtype? [J] .Oncotarget, 2015,6(15):12890-12908.
  • 6Parinyanitikul N, Lei X, Chavez-MacGregor M, et al. Receptorstatus change from primary to residual breast cancer afterneoadjuvant chemotherapy and analysis of survival outcomes[J].Clin Breast Cancer, 2015,15(2):153-160.
  • 7Gamucci T, Vaccaro A, Ciancola F, et al. Recurrence risk in small,node-negative, early breast cancer: a multicenter retrospectiveanalysis[J]. J Cancer Res Clin Oncol, 2013, 139(5):853-860.
  • 8Gonzalez-Angulo AM, Akcakanat A, Liu S, et al. Open-labelrandomized clinical trial of standard neoadjuvant chemotherapywith paclitaxel followed by FEC versus the combination ofpaclitaxel and everolimus followed by FEC in women with triplereceptor-negative breast cancer[J]. Ann Oncol, 2014, 25(6):1122-1127.
  • 9Vaz-Luis I, Ottesen RA, Hughes ME, et al. Outcomes by tumorsubtype and treatment pattern in women with small, node-negativebreast cancer: a multi-institutional study[J]. J Clin Oncol, 2014,32(20):2142-2150.
  • 10Vaz-Luis I,Ottesen RA, Hughes ME, et al. Impact of hormonereceptor status on patterns of recurrence and clinical outcomesamong patients with human epidermal growth factor-2-positivebreast cancer in the National Comprehensive Cancer Network: aprospective cohort study[J]. Breast Cancer Res, 2012, 14(5):R129.doi: 10.1186/bcr3324.

引证文献12

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部